Pharmsville Co., Ltd. Logo

Pharmsville Co., Ltd.

Develops and distributes health supplements and microbiome probiotics globally.

318010 | KO

Overview

Corporate Details

ISIN(s):
KR7318010006
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로3길 37 -, 강서구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharmsville Co., Ltd. is a bio-healthcare company founded in 2000 that specializes in the research, development, production, and distribution of health functional foods and nutritional supplements. The company focuses on creating innovative products, with a particular specialization in microbiome-based probiotics designed to support human wellness. Its product portfolio includes a range of dietary supplements for functions such as energy metabolism and weight management. Operating its own bio-lab, Pharmsville is dedicated to the research and development of new materials for its health products. The company serves its domestic market and exports to a global network of countries across Asia, Europe, and North America.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-13 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.0 KB
2025-05-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 39.9 KB
2025-05-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.3 KB
2025-04-02 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.0 KB
2025-04-02 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 49.4 KB
2025-03-28 00:00
AGM Information
정기주주총회결과
Korean 26.8 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 12.0 KB
2025-03-19 00:00
Audit Report / Information
감사보고서제출
Korean 25.7 KB
2025-03-19 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.6 MB
2025-03-13 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.5 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 165.7 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 15.2 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
Korean 4.6 KB

Automate Your Workflow. Get a real-time feed of all Pharmsville Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharmsville Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharmsville Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD

Talk to a Data Expert

Have a question? We'll get back to you promptly.